According to a recent study by Future Market Insights (FMI), the global balloon catheter market is expected to witness high growth during the forecast period. Sales are expected to reach US$ 5.11 Bn by the end of 2031.This reflects a cumulative CAGR of around 4.0% over the forecast period (2021-2031).Drug eluting ba.
According to a recent study by Future Market Insights (FMI), the global balloon catheter market is expected to witness high growth during the forecast period. Sales are expected to reach US$ 5.11 Bn by the end of 2031. This reflects a cumulative CAGR of around 4.0% over the forecast period (2021-2031).Drug eluting b.
Taipei, April 21 (CNA) The third-phase clinical trial of a drug to treat patients with COVID-19 has officially begun amid a surge in COVID-19 cases in Taiwan, Taiwanese pharmaceutical company PharmaEssentia Corp., the drug's manufacturer, announced Wednesday.